Fractyl Health annual meeting elects three Class II directors, ratifies EY as auditor

FRACTYL HEALTH, INC.

Marc Elia, Clive Meanwell, and Ian Sheffield elected as Class II directors for three-year terms ending 2029.
Ernst & Young LLP ratified as independent auditor for fiscal year ending December 31, 2026.
Approximately 70.7% of outstanding shares represented at the meeting; 112.2 million shares voted.

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

FRACTYL HEALTH, INC. shareholders approved Election of Class II Directors at the 2026-06-10 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-10

Exact text from the filing

Director Nominee For Withheld Broker Non-Vote Marc Elia 65,196,683 9,029,601 38,009,922 Clive Meanwell, M.B., Ch.B., M.D. 63,701,054 10,525,230 38,009,922 Ian Sheffield 73,761,318 464,966 38,009,922

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

FRACTYL HEALTH, INC. shareholders approved Ratification of Independent Auditors at the 2026-06-10 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-10

Exact text from the filing

For Against Abstain 107,931,959 189,715 4,114,532

View on SEC.gov

Browse all shareholder votes →

FRACTYL HEALTH, INC. filing history →

Source: SEC EDGAR

accession 0001193125-26-267897

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.